Coloplast A/S to Issue Dividend of $0.04 (OTCMKTS:CLPBY)

Coloplast A/S (OTCMKTS:CLPBY) announced a dividend on Friday, May 16th, investing.com reports. Shareholders of record on Monday, May 19th will be given a dividend of 0.0389 per share on Thursday, May 22nd. This represents a yield of 2.02%. The ex-dividend date is Friday, May 16th.

Coloplast A/S Stock Up 0.6%

CLPBY stock opened at $9.58 on Friday. Coloplast A/S has a 1-year low of $9.43 and a 1-year high of $14.14. The company has a current ratio of 1.02, a quick ratio of 0.66 and a debt-to-equity ratio of 0.92. The business’s 50-day moving average price is $10.41 and its two-hundred day moving average price is $11.21.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, May 6th. The company reported $0.06 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.03). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. The business had revenue of $1.05 billion for the quarter, compared to analyst estimates of $7.02 billion. On average, research analysts expect that Coloplast A/S will post 0.31 earnings per share for the current year.

Analyst Ratings Changes

CLPBY has been the topic of a number of analyst reports. Barclays cut Coloplast A/S from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 7th. Sanford C. Bernstein upgraded shares of Coloplast A/S from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. Finally, Royal Bank of Canada lowered Coloplast A/S from a “moderate buy” rating to a “hold” rating in a report on Friday, May 9th. Four investment analysts have rated the stock with a hold rating and one has given a strong buy rating to the company. According to MarketBeat.com, Coloplast A/S has a consensus rating of “Hold”.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.